Compare AJANTA PHARMA with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ORCHID PHARMA - Comparison Results

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ORCHID PHARMA AJANTA PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 24.7 -92.2 - View Chart
P/BV x 6.9 26.4 25.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 AJANTA PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ORCHID PHARMA
Sep-13
AJANTA PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs1,422194 732.9%   
Low Rs89835 2,564.6%   
Sales per share (Unadj.) Rs233.5276.5 84.5%  
Earnings per share (Unadj.) Rs44.0-79.2 -55.5%  
Cash flow per share (Unadj.) Rs52.2-43.5 -120.0%  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.153.9 472.9%  
Shares outstanding (eoy) m88.0270.45 124.9%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x5.00.4 1,199.2%   
Avg P/E ratio x26.4-1.4 -1,824.9%  
P/CF ratio (eoy) x22.2-2.6 -843.9%  
Price / Book Value ratio x4.52.1 214.2%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,0818,067 1,265.5%   
No. of employees `0006.82.8 242.9%   
Total wages/salary Rs m4,3072,527 170.4%   
Avg. sales/employee Rs Th3,022.66,956.1 43.5%   
Avg. wages/employee Rs Th633.4902.5 70.2%   
Avg. net profit/employee Rs Th569.1-1,993.0 -28.6%   
INCOME DATA
Net Sales Rs m20,55419,477 105.5%  
Other income Rs m211407 51.8%   
Total revenues Rs m20,76519,884 104.4%   
Gross profit Rs m5,6641,103 513.7%  
Depreciation Rs m7212,519 28.6%   
Interest Rs m125,227 0.2%   
Profit before tax Rs m5,143-6,236 -82.5%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m1,273-125 -1,016.8%   
Profit after tax Rs m3,870-5,580 -69.3%  
Gross profit margin %27.65.7 486.8%  
Effective tax rate %24.82.0 1,233.0%   
Net profit margin %18.8-28.7 -65.7%  
BALANCE SHEET DATA
Current assets Rs m11,81211,014 107.2%   
Current liabilities Rs m3,77632,060 11.8%   
Net working cap to sales %39.1-108.1 -36.2%  
Current ratio x3.10.3 910.5%  
Inventory Days Days7795 81.6%  
Debtors Days Days8234 243.2%  
Net fixed assets Rs m14,39829,440 48.9%   
Share capital Rs m175705 24.9%   
"Free" reserves Rs m22,2772,043 1,090.6%   
Net worth Rs m22,4523,800 590.9%   
Long term debt Rs m79,018 0.1%   
Total assets Rs m26,96246,510 58.0%  
Interest coverage x444.3-0.2 -230,082.9%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.80.4 182.0%   
Return on assets %14.4-0.8 -1,894.0%  
Return on equity %17.2-146.9 -11.7%  
Return on capital %23.0-3.7 -614.5%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m10,6827,513 142.2%   
Fx outflow Rs m2,1025,649 37.2%   
Net fx Rs m8,5801,865 460.2%   
CASH FLOW
From Operations Rs m3,7481,682 222.9%  
From Investments Rs m-2,228-9,860 22.6%  
From Financial Activity Rs m-1,4756,644 -22.2%  
Net Cashflow Rs m45-1,535 -2.9%  

Share Holding

Indian Promoters % 73.8 32.3 228.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 4.6 33.7%  
FIIs % 7.6 3.3 230.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 17.0 55.3 30.7%  
Shareholders   20,968 84,811 24.7%  
Pledged promoter(s) holding % 4.4 54.9 8.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   BIOCON   WOCKHARDT  AUROBINDO PHARMA  PANACEA BIOTECH  FDC  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Mar 5, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS